DocSym
β
Searchsearch
Search
(D82.3) Immunodeficiency following hereditary defective response to epstein-barr virus
More details coming soon
57 978 in individuals diagnosis immunodeficiency following hereditary defective response to epstein-barr virus confirmed
2 889 deaths with diagnosis immunodeficiency following hereditary defective response to epstein-barr virus
5% mortality rate associated with the disease immunodeficiency following hereditary defective response to epstein-barr virus
Diagnosis immunodeficiency following hereditary defective response to epstein-barr virus is diagnosed Men are 15.88% more likely than Women
33 592
Men receive the diagnosis immunodeficiency following hereditary defective response to epstein-barr virus
1 730 (5.2 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
24 386
Women receive the diagnosis immunodeficiency following hereditary defective response to epstein-barr virus
1 159 (4.8 %)Died from this diagnosis.
Risk Group for the Disease immunodeficiency following hereditary defective response to epstein-barr virus - Men and Women aged 5-9
In Men diagnosis is most often set at age 0-19, 25-29, 40-44, 50-64, 70-84
Less common in men the disease occurs at Age 20-24, 30-39, 45-49, 65-69, 85-95+Less common in women the disease occurs at Age 40-44, 50-69, 80-95+
In Women diagnosis is most often set at age 0-39, 45-49, 70-79
Disease Features immunodeficiency following hereditary defective response to epstein-barr virus
Absence or low individual and public risk
Immunodeficiency following hereditary defective response to epstein-barr virus - what does this mean
Immunodeficiency following hereditary defective response to epstein-barr virus occurs when an individual inherits a gene mutation that results in their immune system being unable to effectively respond to the epstein-barr virus, leading to a weakened immune response and an increased risk of infection.
What happens during the disease - immunodeficiency following hereditary defective response to epstein-barr virus
The pathogenesis of immunodeficiency following a hereditary defective response to epstein-barr virus (ebv) is due to a malfunction of the immune system in response to the virus. this is caused by a genetic mutation that affects the body's ability to recognize and respond to ebv, resulting in an impaired immune system and increased risk of infection. this can lead to a weakened immune system, making it more difficult for the body to fight off infections and other diseases.
Clinical Pattern
More details coming soon
How does a doctor diagnose
More details coming soon
Treatment and Medical Assistance
More details coming soon
8 Days of Hospitalization Required
55 Hours Required for Outpatient Treatment
Immunodeficiency following hereditary defective response to epstein-barr virus - Prevention
The best way to prevent immunodeficiency following hereditary defective response to epstein-barr virus is to ensure that individuals with a family history of the condition receive regular check-ups and are tested for any signs of the virus. vaccination against the virus is also recommended, as well as maintaining a healthy lifestyle and avoiding contact with individuals who have the virus.